Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Compare 2024 dividend aristocrats ETF fees to find the lowest cost option. This guide highlights expense ratios and what to look for in a low-cost fund.
27,654 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A sweeping budget package introduced in Congress is fuelling new concerns over Social Security and Medicare solvency,...
New disclosures and reports tie Axon shares to a high-profile purchase before a major federal contract, prompting scr...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
A wave of review requests is reshaping consumer habits and small-business budgets in early 2026. Experts warn of a fe...
Bitcoin steadies above $60k as traders weigh a delicate recovery against stubborn resistance. The coming days will cl...
Bittensor's TAO aims to blend AI training services with blockchain incentives. After a sharp rally, investors wonder ...
The Federal Reserve Bank Minneapolis signals ongoing inflation uncertainty, stressing that price gains are easing but...
U.S. gasoline stocks have fallen for 14 consecutive weeks, pushing Memorial Day prices toward four-year highs as WTI ...
A mounting deficit of $3.4 trillion is shaping long-term borrowing costs, with the 30-year fixed mortgage lingering n...
Oil faces a slow path back to $67 a barrel, with supply resilience and geopolitics keeping gains limited. Analysts sa...
Tenable has bumped higher again, fueled by fresh analyst optimism and stronger demand for cybersecurity tools. This g...